Vitality Watch

Dossier rss preclinical 29-sep-2026
Animal model, organoid, or cell-culture result — not yet human

IGF‐1/SLC25A33 Maintains Blood‐Labyrinth Barrier Integrity by Suppressing TGF‐β/Smad2‐Mediated Pericyte Activation in Age‐Related Hearing Loss

Key claim: IGF-1/SLC25A33 preserves blood-labyrinth barrier integrity in age-related hearing loss by suppressing TGF-β/Smad2-mediated pericyte activation.

Abstract

Aging Cell, Volume 25, Issue 10, October 2026.

Why this matters

Age-related hearing loss has primarily been framed as hair-cell and cochlear-neuron degeneration, but this paper locates a parallel lesion in the cochlear microvasculature: IGF-1 acting through the mitochondrial carrier SLC25A33 keeps pericytes from being activated by TGF-β/Smad2, and loss of that restraint degrades the blood-labyrinth barrier. It connects the systemic GH/IGF-1 aging axis to a specific pericyte-barrier mechanism in a sensory organ, mirroring BBB-pericyte stories already logged for brain aging. The evidence is preclinical pathway detail, not a human-translatable intervention.

Source

Link

Briefing card

IGF‐1/SLC25A33 Maintains Blood‐Labyrinth Barrier Integrity by Suppressing TGF‐β/Smad2‐Mediated Pericyte Activation in Age‐Related Hearing Loss
Stage: preclinical · rss · 29-sep-2026

Applies to researchers tracking IGF-1 and pericyte biology in age-related hearing loss; no action for people with hearing loss today.

IGF-1/SLC25A33 preserves blood-labyrinth barrier integrity in age-related hearing loss by suppressing TGF-β/Smad2-mediated pericyte activation.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://onlinelibrary.wiley.com/doi/10.1111/acel.70712?af=R

build build 880 · 2bcef25 · 2026-11-18